AU1165899A - Conjugates comprising two active agents - Google Patents

Conjugates comprising two active agents

Info

Publication number
AU1165899A
AU1165899A AU11658/99A AU1165899A AU1165899A AU 1165899 A AU1165899 A AU 1165899A AU 11658/99 A AU11658/99 A AU 11658/99A AU 1165899 A AU1165899 A AU 1165899A AU 1165899 A AU1165899 A AU 1165899A
Authority
AU
Australia
Prior art keywords
active agents
conjugates
carrier
linker
functional group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11658/99A
Other languages
English (en)
Inventor
Nicola Jane Church
Roy Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Healthcare UK Ltd
Original Assignee
Quadrant Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadrant Healthcare UK Ltd filed Critical Quadrant Healthcare UK Ltd
Publication of AU1165899A publication Critical patent/AU1165899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU11658/99A 1997-11-14 1998-11-16 Conjugates comprising two active agents Abandoned AU1165899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9724143.4A GB9724143D0 (en) 1997-11-14 1997-11-14 Pharmaceutical conjugate
GB9724143 1997-11-14
PCT/GB1998/003442 WO1999025383A1 (en) 1997-11-14 1998-11-16 Conjugates comprising two active agents

Publications (1)

Publication Number Publication Date
AU1165899A true AU1165899A (en) 1999-06-07

Family

ID=10822123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11658/99A Abandoned AU1165899A (en) 1997-11-14 1998-11-16 Conjugates comprising two active agents

Country Status (9)

Country Link
US (1) US7001989B2 (https=)
EP (1) EP1047452B1 (https=)
JP (1) JP2001523648A (https=)
AT (1) ATE293459T1 (https=)
AU (1) AU1165899A (https=)
DE (1) DE69829880T2 (https=)
ES (1) ES2238774T3 (https=)
GB (1) GB9724143D0 (https=)
WO (1) WO1999025383A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933366B2 (en) * 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
WO1999064072A1 (de) * 1998-06-10 1999-12-16 Baxter Aktiengesellschaft Konjugat, bestehend aus einem lektin und einem blutgerinnungsfaktor
GB9825105D0 (en) * 1998-11-16 1999-01-13 Andaris Ltd Pharamaceutical conjugates
GB9827813D0 (en) * 1998-12-17 1999-02-10 Andaris Ltd Pharmaceutical conjugates
DE19926475A1 (de) * 1999-06-10 2000-12-14 Ktb Tumorforschungs Gmbh Träger-Pharmaka-Konjugate
AU6389000A (en) * 1999-07-28 2001-02-19 Valentis, Inc. Sonoporation of tumors
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
NZ572531A (en) 2006-05-05 2011-09-30 Univ Michigan Bivalent smac mimetics and the uses thereof
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US20090170195A1 (en) * 2007-12-28 2009-07-02 Kent State University Curcumin-hyaluronan compounds
CN102112144A (zh) * 2008-05-16 2011-06-29 拜耳医药保健有限公司 靶向性凝固因子及其使用方法
ES2427627T3 (es) * 2009-04-06 2013-10-31 Novo Nordisk A/S Entrega dirigida de proteínas de Factor VIII a plaquetas
GB201101740D0 (en) 2011-02-01 2011-03-16 Haemostatix Ltd Therapeutic agents with improved fibrinogen binding

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970300A (en) * 1985-02-01 1990-11-13 New York University Modified factor VIII
IL85372A (en) * 1987-02-12 1992-12-01 Us Health Penta to nona-peptides with laminin - like activity having an amino acid sequence and anti- metastatic compositions containing them
US5716614A (en) * 1994-08-05 1998-02-10 Molecular/Structural Biotechnologies, Inc. Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
BR9510462A (pt) * 1994-12-16 1998-12-15 Andaris Ltd Micropartículas reticuladas e seu uso como veículos terapéuticos
AU6100296A (en) 1995-06-06 1996-12-24 Hemosphere, Inc. Protein particles for therapeutic and diagnostic use
WO1998017319A2 (en) * 1996-10-21 1998-04-30 Quadrant Healthcare (Uk) Limited Platelet substitutes and conjugation methods suitable for their preparation

Also Published As

Publication number Publication date
ATE293459T1 (de) 2005-05-15
DE69829880D1 (de) 2005-05-25
GB9724143D0 (en) 1998-01-14
EP1047452A1 (en) 2000-11-02
DE69829880T2 (de) 2005-09-22
US7001989B2 (en) 2006-02-21
US20030087826A1 (en) 2003-05-08
WO1999025383A1 (en) 1999-05-27
JP2001523648A (ja) 2001-11-27
ES2238774T3 (es) 2005-09-01
EP1047452B1 (en) 2005-04-20

Similar Documents

Publication Publication Date Title
AU1165899A (en) Conjugates comprising two active agents
EP1374908A3 (en) Polymer-drug conjugates comprising hydrazide linkers
IL131651A0 (en) A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
CA2309818A1 (en) Buffered drug formulations for transdermal electrotransport delivery
CA2166931A1 (en) Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon
PT1176961E (pt) Sistemas de administracao de nicotina
AU5956398A (en) Remedies for lymphocytic tumors
DK1036058T3 (da) Adamantanderivater
DE69808130D1 (de) Adamantan-derivate
MX9603570A (es) Metodo y composiciones para incrementar la vida media en suero de agentes farmacologicamente activos.
AU7667398A (en) Integrin-targeting vectors having transfection activity
ZA981029B (en) Pharmaceutical agents.
SG168401A1 (en) Catalyst and use thereof
BR9808770A (pt) Conjugado medicamentoso, método para suaprodução e seu uso
AU2460499A (en) Vanadium (iv) metallocene complexes having spermicidal activity
UA32522C2 (uk) Ліофілізована протипухлинна композиція і стерильна водна композиція для ін'єкцій на її основі
WO1997023240A3 (de) Konjugat, umfassend einen wirkstoff, ein polypeptid und einen polyether
AU8414098A (en) Noscapine derivatives, useful as anticancer agents
DE60041351D1 (de) Gssytem
EP1084710A4 (en) DRUGS AGAINST MALE STERILITY
DK0815141T3 (da) Antistof mod et fusionspolypeptid omfattende en histidinandel
ES2183346T3 (es) Sistemas conjugados de bis-fosfonato con restos alquilantes que tienen actividad antitumoral.
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
DE69830333D1 (de) SCHNELLÖSLICHE ARZNEIMITTELZUSAMMENSETZUNG ENTHALTEND MIKRONISiERTE AS-3201
AU1067200A (en) Pharmaceutical conjugates comprising two active agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase